When to admit a patient with community-acquired pneumonia;Cuándo ingresar una neumonía adquirida en la communidad

Archivos de Bronconeumologia

Volumn 38, Issue 12, 2002, Pages 549-551

  Capelastegui, A ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; COMMUNITY; EDITORIAL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MEDICAL DECISION MAKING; MEDICAL SOCIETY; OUTPATIENT CARE; OXYGENATION; PNEUMONIA; VALIDATION PROCESS;

EID: 0036934372     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-2896(02)75288-5     Document Type: Editorial

References (26)

1. Woodhead MA, Macfarlane JT, McCraken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987;1:671-4.
2. Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Karkola K, Korppi M, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993;137:977-88.
3. Foy HM, Cooney MK, Allan I, Kenny GE. Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975. JAMA 1979;241:253-8.
4. Suchyta MR, Dean NC, Narus S, Hadlock CJ. Effects of a practice guideline for community-acquired pneumonia in an outpatient setting. Am J Med 2001;110:306-9.
5. Marrie TJ, Lau CY, Wheeler SL. Wong CJ, Vandervoort MK, Feagan BG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. JAMA 2000;283:749-55.
6. Almirall J, Bolíbar I, Vidal J, Sauca G, Coll P, Niklasson B, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 2000;15:757-63.
7. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA 1996;275:134-41.
8. Ewig S, Ruiz M, Mensa J, Marcos MA. Martinez JA. Arancibia F, et al. Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med 1998;158:1102-8.
9. McCormick D, Fine MJ. Coley CM, Marrie TJ, Lave JR, Obronsky DS, et al. Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes? Am J Med 1999;107:5-12.
10. Wennberg JE, Freeman JL, Culp WJ. Are hospital services rationed in New Haven or over-utilised in Boston? Lancet 1987;1:1185-9.
11. Dorca J, Bello S, Blanquer J, De Cells R, Molinos I, Torres A, et al. Diagnóstico y tatamiento de la neumonía adquirida en la comunidad. Arch Bronconeumol 1997;33:240-6.
12. Macfarlane J, Boswell T, Douglas G, Finch R, Holmes W, Honeybourne D, et al. BTS guidelines for the management of community-acquired pneumonia in adults. Thorax 2001;156(Suppl 4):1-64.
13. Neill AM, Martin IR, Weir R, Anderson R, Chereshsky A, Epton MJ, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996;51:1010-6.
14. Farr BM. Sloman AJ, Fisch MJ. Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med 1991;115:428-36.
15. Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, et al. Study of community-acquired pneumonia aetiology in adults admitted to hospital: implications for management guidelines. Thorax 2001;56:296-301.
16. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al. Guideline for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730-54.
17. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
18. Aronsky D, Dean NC. How should we make the admission decision in community-acquired pneumonia? Med Clin North Am 2001;85:1397-411.
19. Atlas SJ, Benzer TI, Borowsky LH, Chang Y, Burnham DC, Metlay JP, et al. Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients. Arch Intern Med 1998;158:1350-6.
20. Ruiz A, Vallverdú M, Falguera M, Perez J, Cabré X, Almirall M, et al. Neumonía adquirida en la comunidad: impacto de la utilización de una estrategia terapéutica basada en la mortalidad a corto plazo. Med Clin (Barc) 1999;113:85-8.
21. Rosón B, Carratalá J, Dorca J, Casanova A, Manresa F, Gudiol F. Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis 2001;33:158-65.
22. Menéndez R, Ferrando D, Vallés JM, Martinez E, Perpiñá M. Initial risk class and length of hospital stay in community-acquired pneumonia. Eur Respir J 2001;18:151-6.
23. Marras TK, Gutiérrez C, Chan CK. Applying a prediction rule to identify low-risk patients with community-acquired pneumonia, Chest 2000;118:1339-43.
24. González-Moraleja J, Sesma P, González C, López ME, García JF, Álvarez-Sala JL. ¿Cuál es el coste de las neumonías que ingresamos inadecuadamente? Arch Bronconeumol 1999;35:312-6.
25. España P, Capelastegui A, Quintana JM, Soto A, Gorordo I, Garcia-Urbaneja M, et al. A prediction rule to identify allocation of inpatient care in community-acquired pneumonia. Eur Respir J 2002 [en prensa].
26. Halm EA, Atlas SJ, Boroswsky LH, Benzer TH, Metlay JP, Chang Y, et al. Understanding physician adherence with a pneumonia practice guideline. Arch Intern Med 2000;160:98-104.